Fermata Pharma Inc. is a privately held company based in New York, NY, dedicated to developing innovative treatments for a range of diseases including Alzheimer's disease, lung cancer, an orphan disease, lymphangio-leiomyomatosis, and COVID-19.
The company's research efforts also extend to exploring the potential benefits of shingles vaccination in reducing the risk of Alzheimer's and Parkinson's Disease, as presented at the National Vaccine Advisory Committee Meeting in Washington, D.C. on September 22, 2022.
Generated from the website